David Shaw’s Aspire Biopharma Warrant ASBPW Stock Holding History

David Shaw’s Portfolio ASBPW Stock Details ASBPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.1K	Hold	199,999	–	–	﹤0.01%	4810
2026 Q1	$3.32K	Hold	199,999	–	–	﹤0.01%	4452
2025 Q4	$3.3K	Hold	199,999	–	–	﹤0.01%	4536
2025 Q3	$5.98K	Hold	199,999	–	–	﹤0.01%	4481
2025 Q2	$8.94K	Hold	199,999	–	–	﹤0.01%	4256
2025 Q1	$13.5K	Hold	199,999	–	–	﹤0.01%	4122
2024 Q4	$9.5K	Hold	199,999	–	–	﹤0.01%	4280
2024 Q3	$8.46K	Hold	199,999	–	–	﹤0.01%	4394
2024 Q2	$6.02K	Hold	199,999	–	–	﹤0.01%	4351
2024 Q1	$6.02K	Hold	199,999	–	–	﹤0.01%	4207
2023 Q4	$12K	Hold	199,999	–	–	﹤0.01%	4107
2023 Q3	$10K	Hold	199,999	–	–	﹤0.01%	4059
2023 Q2	$10K	Hold	199,999	–	–	﹤0.01%	4048
2023 Q1	$8.36K	Hold	199,999	–	–	﹤0.01%	4258
2022 Q4	$16K	Hold	199,999	–	–	﹤0.01%	4553
2022 Q3	$34K	Hold	199,999	–	–	﹤0.01%	4741
2022 Q2	$24K	Buy	+199,999	New	+$43.5K	﹤0.01%	4979

Other funds holding ASBPW

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

David Shaw's ASBPW Position: Q2 2026 in Review

David Shaw held its Aspire Biopharma Warrant (ASBPW) position steady in Q2 2026 at 199,999 shares worth $4.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4810.

David Shaw first reported a position in ASBPW in Q2 2022 and has held it in 17 quarters since. The position peaked at $34K in Q3 2022. 27 funds tracked by Wall St. Rank hold ASBPW as of Q2 2026.

David Shaw held 199,999 shares of Aspire Biopharma Warrant worth $4.1K as of Q2 2026.
David Shaw left its Aspire Biopharma Warrant share count unchanged in Q2 2026.
Aspire Biopharma Warrant made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4810 holding.
David Shaw first reported a position in Aspire Biopharma Warrant in Q2 2022 and has held it in 17 quarters since.
David Shaw's Aspire Biopharma Warrant position peaked at $34K in Q3 2022.
27 funds tracked by Wall St. Rank held Aspire Biopharma Warrant as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.